At baseline, pruritus was reported in the placebo arm in 19%, 22%, and 15% of cases treated with the different farnesoid X receptor (FXR) agonists obeticholic acid (OCA), tropifexor, and cilofexor, respectively [5]. The gene discussed is NR1H4; the disease is Pruritus.